BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38632300)

  • 21. Glutathionylation on RNA-binding proteins: a regulator of liquid‒liquid phase separation in the pathogenesis of amyotrophic lateral sclerosis.
    Choi HJ; Lee JY; Kim K
    Exp Mol Med; 2023 Apr; 55(4):735-744. PubMed ID: 37009800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperosmotic-stress-induced liquid-liquid phase separation of ALS-related proteins in the nucleus.
    Gao C; Gu J; Zhang H; Jiang K; Tang L; Liu R; Zhang L; Zhang P; Liu C; Dai B; Song J
    Cell Rep; 2022 Jul; 40(3):111086. PubMed ID: 35858576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Post-Translational Modifications on Prion-Like Aggregation and Liquid-Phase Separation of FUS.
    Rhoads SN; Monahan ZT; Yee DS; Shewmaker FP
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29547565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
    Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
    Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules.
    Bosco DA; Lemay N; Ko HK; Zhou H; Burke C; Kwiatkowski TJ; Sapp P; McKenna-Yasek D; Brown RH; Hayward LJ
    Hum Mol Genet; 2010 Nov; 19(21):4160-75. PubMed ID: 20699327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.
    Liu X; Chen J; Liu W; Li X; Chen Q; Liu T; Gao S; Deng M
    Neurogenetics; 2015 Jul; 16(3):223-31. PubMed ID: 25912081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic modulation of GSTO activity rescues FUS-associated neurotoxicity via deglutathionylation in ALS disease models.
    Cha SJ; Lee S; Choi HJ; Han YJ; Jeon YM; Jo M; Lee S; Nahm M; Lim SM; Kim SH; Kim HJ; Kim K
    Dev Cell; 2022 Mar; 57(6):783-798.e8. PubMed ID: 35320731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging.
    Japtok J; Lojewski X; Naumann M; Klingenstein M; Reinhardt P; Sterneckert J; Putz S; Demestre M; Boeckers TM; Ludolph AC; Liebau S; Storch A; Hermann A
    Neurobiol Dis; 2015 Oct; 82():420-429. PubMed ID: 26253605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay.
    Kamelgarn M; Chen J; Kuang L; Jin H; Kasarskis EJ; Zhu H
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11904-E11913. PubMed ID: 30455313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights into the Atomistic Mechanisms of Phosphorylation in Disrupting Liquid-Liquid Phase Separation and Aggregation of the FUS Low-Complexity Domain.
    Lao Z; Dong X; Liu X; Li F; Chen Y; Tang Y; Wei G
    J Chem Inf Model; 2022 Jul; 62(13):3227-3238. PubMed ID: 35709363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The
    Yokoi S; Ito T; Sahashi K; Nakatochi M; Nakamura R; Tohnai G; Fujioka Y; Ishigaki S; Udagawa T; Izumi Y; Morita M; Kano O; Oda M; Sone T; Okano H; Atsuta N; Katsuno M; Okada Y; Sobue G
    J Neurosci; 2022 Nov; 42(47):8881-8896. PubMed ID: 36261283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autophagy regulates amyotrophic lateral sclerosis-linked fused in sarcoma-positive stress granules in neurons.
    Ryu HH; Jun MH; Min KJ; Jang DJ; Lee YS; Kim HK; Lee JA
    Neurobiol Aging; 2014 Dec; 35(12):2822-2831. PubMed ID: 25216585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis.
    Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH
    Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import.
    Dormann D; Rodde R; Edbauer D; Bentmann E; Fischer I; Hruscha A; Than ME; Mackenzie IR; Capell A; Schmid B; Neumann M; Haass C
    EMBO J; 2010 Aug; 29(16):2841-57. PubMed ID: 20606625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin inhibits liquid-liquid phase separation of fused in sarcoma and attenuates the sequestration of pyruvate kinase to restore cellular metabolism.
    Shi WP; Lin WJ; Ge WY; Chen LL; Zhang TD; Guo WH; Liu JL; Yin DC
    Food Funct; 2023 May; 14(10):4621-4631. PubMed ID: 37158592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autophagy meets fused in sarcoma-positive stress granules.
    Matus S; Bosco DA; Hetz C
    Neurobiol Aging; 2014 Dec; 35(12):2832-2835. PubMed ID: 25444610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function.
    Murakami T; Qamar S; Lin JQ; Schierle GS; Rees E; Miyashita A; Costa AR; Dodd RB; Chan FT; Michel CH; Kronenberg-Versteeg D; Li Y; Yang SP; Wakutani Y; Meadows W; Ferry RR; Dong L; Tartaglia GG; Favrin G; Lin WL; Dickson DW; Zhen M; Ron D; Schmitt-Ulms G; Fraser PE; Shneider NA; Holt C; Vendruscolo M; Kaminski CF; St George-Hyslop P
    Neuron; 2015 Nov; 88(4):678-90. PubMed ID: 26526393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis.
    Sabatelli M; Moncada A; Conte A; Lattante S; Marangi G; Luigetti M; Lucchini M; Mirabella M; Romano A; Del Grande A; Bisogni G; Doronzio PN; Rossini PM; Zollino M
    Hum Mol Genet; 2013 Dec; 22(23):4748-55. PubMed ID: 23847048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FUS fibrillation occurs through a nucleation-based process below the critical concentration required for liquid-liquid phase separation.
    Bertrand E; Demongin C; Dobra I; Rengifo-Gonzalez JC; Singatulina AS; Sukhanova MV; Lavrik OI; Pastré D; Hamon L
    Sci Rep; 2023 May; 13(1):7772. PubMed ID: 37179431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation.
    Sama RR; Fallini C; Gatto R; McKeon JE; Song Y; Rotunno MS; Penaranda S; Abdurakhmanov I; Landers JE; Morfini G; Brady ST; Bosco DA
    Sci Rep; 2017 Mar; 7(1):115. PubMed ID: 28273913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.